2,886
Views
3
CrossRef citations to date
0
Altmetric
HPV – Article Commentary

Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9

ORCID Icon
Article: 2146434 | Received 15 Aug 2022, Accepted 08 Nov 2022, Published online: 20 Nov 2022

References

  • Pickering LK, Orenstein WA. Development of pediatric vaccine recommendations and policies. Semin Pediatr Infect Dis. 2002 Jul;13(3):1–3. doi:10.1053/spid.2002.125857.
  • Markowitz LE, Dunne EF, Saraiya M, Harrell WC, Robinette CC, Julianne G, Joseph AB Jr, Elizabeth RU. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007 Mar 23;56(RR–2):1–24.
  • Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, Crowe SJ, Stokley S, Singleton JA. National vaccination coverage among adolescents aged 13–17 years—National Immunization Survey-Teen, United States, 2021. MMWR Morb Mortal Wkly Rep. 2022 Sep 2;71(35):1101–08. doi:10.15585/mmwr.mm7135a1.
  • Adams DA, Thomas KR, Jajosky RA, Foster L, Baroi G, Sharp P, Onweh DH, Schley AW, Anderson WJ. Summary of notifiable infectious diseases and conditions—United States, 2015. MMWR Morb Mortal Wkly Rep. 2017 Aug 11;64(53):1–143. doi:10.15585/mmwr.mm6453a1.
  • Henley SJ, Singh SD, King J, Wilson RJ, O’Neil ME, Ryerson AB. Invasive cancer incidence and survival—United States, 2013. MMWR Morb Mortal Wkly Rep. 2017 Jan 27;66(3):69–75. doi:10.15585/mmwr.mm6603a1.
  • Institute NC. Accessed. 2022 Oct 17. https://seer.cancer.gov/statfacts/html/cervix.html
  • Farias AJ, Savas LS, Fernandez ME, Coan SP, Shegog R, Healy CM, Lipizzi E, Vernon SW. Association of physicians perceived barriers with human papillomavirus vaccination initiation. Prev Med. 2017 Dec;105:219–25. doi:10.1016/j.ypmed.2017.07.016.
  • Allison MA, Hurley LP, Markowitz L, Crane LA, Brtnikova M, Beaty BL, Snow M, Cory J, Stokley S, Roark J, et al. Primary care physicians’ perspectives about HPV vaccine. Pediatrics. 2016 Feb;137(2):e20152488. doi:10.1542/peds.2015-2488.
  • Middleman AB, Rosenthal SL, Rickert VI, Neinstein L, Fishbein DB, D’Angelo L. Adolescent immunizations: a position paper of the Society for Adolescent Medicine. J Adolesc Health. 2006 Mar;38(3):321–27. doi:10.1016/j.jadohealth.2006.01.002.
  • Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Recomm Rep. 1996. Nov 22;45(RR–13):1–16.
  • Data Resource Center For Child & Adolescent Health. 2016. National survey of children’s health. [accessed. 2018 Feb 8]. http://www.childhealthdata.org/browse/survey/results?q=4684&r=1&g=604.
  • Moss JL, Reiter PL, Brewer NT. Concomitant adolescent vaccination in the U.S., 2007-2012. Am J Prev Med. 2016 Nov;51(5):693–705. doi:10.1016/j.amepre.2016.05.013.
  • Hofstetter AM, Stockwell MS, Al-Husayni N, Ompad D, Natarajan K, Rosenthal SL, Soren K. HPV vaccination: are we initiating too late? Vaccine. 2014 Apr 7;32(17):1939–45. doi:10.1016/j.vaccine.2014.01.084.
  • Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874–82. doi:10.15585/mmwr.mm6633a2.
  • Kjaer SK, Nygard M, Dillner J, Brooke Marshall J, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, et al. A 12-Year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 nordic countries. Clin Infect Dis, 2018 Jan 18;66(3):339–45. doi:10.1093/cid/cix797.
  • [accessed. 2022 Jul 26]. https://clinicaltrials.gov/ct2/show/NCT04722822
  • St Sauver JL, Rutten LJ, Ebbert JO, Jacobson DJ, McGree ME, Jacobson RM. Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. Prev Med. 2016 Aug;89:327–33. doi:10.1016/j.ypmed.2016.02.039.
  • Hirth JM, Tan A, Wilkinson GS, Berenson AB. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer. 2012 Nov 15;118(22):5623–29. doi:10.1002/cncr.27598.
  • Rubin RF, Kuttab HM, Rihani RS, Reutzel TJ. Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice. J Community Health. 2012 Dec;37(6):1145–50. doi:10.1007/s10900-012-9581-9.
  • Goleman MJ, Dolce M, Morack J. Quality improvement initiative to improve human papillomavirus vaccine initiation at 9 years of age. Acad Pediatr. 2018 Sep - Oct;18(7):769–75. doi:10.1016/j.acap.2018.05.005.
  • Biancarelli DL, Drainoni ML, Perkins RB. Provider experience recommending HPV vaccination before age 11 years. J Pediatr. 2020 Feb;217:92–97. doi:10.1016/j.jpeds.2019.10.025.
  • Perkins RB, Legler A, Jansen E, Bernstein J, Pierre-Joseph N, Eun TJ, Biancarelli DL, Schuch TJ, Leschly K, Fenton ATHR, et al. Improving HPV vaccination rates: a stepped-wedge randomized trial. Pediatrics. 2020 Jul;146(1). doi:10.1542/peds.2019-2737.
  • Bernstein HH, Bocchini JA Jr. Committee on Infectious D. Practical approaches to optimize adolescent immunization. Pediatrics. 2017 Mar;139(3). doi:10.1542/peds.2016-4187.